Now Available: CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Australia

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Australia

Summary

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Australia". The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Australia. It identifies the key trends in the country's healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

Full Report Details at
- http://www.fastmr.com/prod/880695_countryfocus_healthcare_regulatory_and.aspx?afid=301

The population of Australia in 2013 was 23.2 million, having grown at a CAGR of 1.6% from 2008. Medicare is Australia's public health insurance scheme, and provides free or subsidized healthcare services to the Australian population. The government is attempting to reduce the barriers to manufacturing drugs and encourage exports through the introduction of various new policies.

In 2013, the government spent $1 billion on R&D on medical and health science and exported $3.8 billion of pharmaceutical products. The pharmaceutical market in Australia was worth $18 billion in 2008 and is projected to reach $32 billion by 2020, at a Compound Annual Growth Rate (CAGR) of 5.1%. The medical device market was valued at $5.9 billion in 2008 and is projected to grow at a CAGR of 4.9% to $10.4 billion by 2020. These positive growth trends can be primarily attributed to -

* An increasingly elderly population
* Universal health coverage
* Government initiatives

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Australia, and includes -

* An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
* Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, AstraZeneca, Novartis, Sanofi and Alphapharm; and profiles and SWOT analyses of the major players in the medical device market: Siemens Healthcare, GE Healthcare, Medtronic, DePuy companies and F.Hoffmann-La Roche
* An insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country's healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
* Detailed analysis of the country's political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
* An overview of the opportunities for and challenges to growth in the Australian healthcare market

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Brazil
- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Mexico
- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia
- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - India
- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Turkey